Advanced search
Publication Cover
Redox Report
Communications in Free Radical Research
Volume 7, 2002 - Issue 2
Submit an article Journal homepage
545
Views
19
CrossRef citations to date
0
Altmetric
Review

Biological regulation through protein disulfide bond cleavage

Philip J. HoggCentre for Thrombosis and Vascular Research School of Medical Sciences, University of New South Wales and Department of Haematology, Prince of Wales Hospital, Sydney, New South Wales, Australia
Pages 71-77 | Published online: 19 Jul 2013

  • Noiva R. Enzymatic catalysis of disulfide formation. Protein Expr Purif 1994; 5: 1–13.
  • Pace CN, Grimsley GR, Thomson JA, Barnett BJ. Conformational stability and activity of ribonuclease T1 with zero, one, and two intact disulfide bonds. J Biol Chem 1988; 263: 11820–11825.
  • Wetzel R. Harnessing disulfide bonds using protein engineering. Trends Biol Sci 1987; 12: 478–482.
  • Thornton JM. Disulphide bridges in globular proteins. J Mol Biol 1981;151: 261–287.
  • Lay AJ, Jiang X-M, Kisker 0 et al. Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase. Nature 2000; 408: 869–873.
  • Xie L, Chesterman CN, Hogg PJ. Control of von Willebrand factor multimer size by thrombospondin-1.J Exp Med 2001; 193: 1341–1349.
  • Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31.
  • O'Reilly MS, Holmgren L, Shing Y et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315–328.
  • O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996;2: 689–692.
  • Sim BKL, O'Reilly MS, Liang H et al. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 1997; 57: 1329–1334.
  • Lannutti BJ, Gately ST, Quevedo ME, Soff GA, Paller AS. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. Cancer Res 1997; 57: 5277–5280.
  • Claesson-Welsh L, Welsh M, Ito N et al. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA 1998; 95: 5579–5583.
  • Moser TL, Kenan DJ, Ashley TA et al. Endothelial cell surface Fl-FO ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA 2001; 98: 6656–6661.
  • Lijnen HR. Elements of the fibrinolytic system. Ann NY Acad Sci 2001; 936: 226–236.
  • Stathakis P, Lay AJ, Fitzgerald M, Schlieker C, Matthias LJ, Hogg PJ. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin. J Biol Chem 1999; 274: 8910–8916.
  • Stathakis P, Fitzgerald M, Matthias 1_,J, Chesterman CN, Hogg PJ. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells. J Biol Chem 1997;272: 20641–20645.
  • Gately S, Twardowski P, Stack MS et al. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci USA 1997; 94: 10868–10872.
  • Bannai S, Tsukeda H. The export of glutathione from human diploid cells in culture. J Biol Chem 1979; 254: 3444–3450.
  • Dethmers JK, Meister A. Glutathione export by human lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation. Proc Natl Acad Sci USA 1981;78: 7492–7496.
  • Wu H-L, Shi G-Y, Bender ML. Preparation and purification of microplasmin. Proc Natl Acad Sci USA 1987; 84: 8292–8295.
  • Wu H-L, Shi G-Y, Wohl RC, Bender ML. Structure and formation of microplasmin. Proc Natl Acad Sci USA 1987; 84: 8793–8795.
  • Kassam G, Kwon M, Yoon CS et al. Purification and characterization of A61. An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors. J Biol Chem 2001; 276: 8924–8933.
  • Gately S, Twardowski P, Stack MS et al. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res 1996; 56: 4887–4890.
  • Vishwanatha JK, Jindal HK, Davis RG. The role of primer recognition proteins in DNA replication: association with nuclear matrix in HeLa cells. J Cell Sci 1992; 101: 25–34.
  • Popanda O, Fox G, Thielmann HW. Modulation of DNA polymerases alpha, delta and epsilon by lactate dehydrogenase and 3-phosphoglyceratekinase. Biochim Biophys Acta 1998; 1397: 102–117.
  • Ogino T, Iwama M, Kinouchi J, Shibagaki Y, Tsukamoto T, Mizumoto K. Involvement of a cellular glycolytic enzyme, phosphoglycerate kinase, in Sendai virus transcription. J Biol Chem 1999; 274: 35999–36008.
  • Alloush HM, La M, Kinouchi J, Shibagaki Y, Tsukamoto T, Mizumoto K. 3-Phosphoglyceratekinase: a glycolytic enzyme protein present in the cell wall of Candida albi cans. Microbiology 1997; 143: 321-330.
  • Banks RD, Blake CCF, Evans PR et al. Sequence, structure and activity of phosphoglycerate kinase: a possible hinge-bending enzyme. Nature 1979; 279: 773–777.
  • Watson HC, Walker NPC, Shaw PJ et al. Sequence and structure of yeast phosphoglycerate kinase. EMBO J 1982; 1: 1635–1640.
  • Blake CCF, Evans PR. Structure of horse muscle phosphoglycerate kinase. Some results on the chain conformation, substrate binding and evolution of the molecule from a 3 Angstrom Fourier map. J Mol Biol 1974; 84: 585–601.
  • Harlos K, Vas M, Blake CCF. Crystal structure of the binary complex of pig muscle phosphoglycerate kinase and its substrate 3-phospho-D-glycerate. Proteins 1992; 12: 133–144.
  • May A, Vas M, Harlos K, Blake C. 2.0 A resolution structure of a ternary complex of pig muscle phosphoglycerate kinase containing 3-phospho-D-glycerate and the nucleotide Mn adenylylimidodiphosphate. Proteins 1996; 24: 292–303.
  • Szilágyi AN, Ghosh M, Garman E, Vas M. A 1.8 A resolution structure of pig muscle 3-phosphoglyceratekinase with bound MgADP and 3-phosphoglycerate in open conformation: new insight into the role of the nucleotide in domain closure. J Mol Biol 2001; 306: 499–511.
  • Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 1989; 264: 13963–13966.
  • Noiva R. Protein disulfide isomerase: the multifunctional redox chap-erone of the endoplasmic reticulum. Cell Dev Biol 1999; 10:481–493.
  • Cserpan I, Vas M. Effects of substrates on the heat stability and on the reactivities of thiol groups of 3-phosphoglyceratekinase. Eur J Biochem 1983;131: 157–162.
  • Minard P, Desmadril M, Ballery N, Perahia D, Mouawad L. Study of the fast-reacting cysteines in phosphoglycerate kinase using chemical modification and site-directed mutagenesis. Eur J Biochem 1989; 185:419–423.
  • Lay AJ, Jiang X-M, Daly E, Sun L, Hogg PJ. Plasmin reduction by phosphoglycerate kinase is a thiol-independent process. J Biol Chem 2002; In press.
  • McHarg J, Kelly SM, Price NC, Cooper A, Littlechild JA. Site-directed mutagenesis of proline 204 in the ‘hinge’ region of yeast phosphoglycerate kinase. Eur J Biochem 1999; 259: 939–945.
  • Weiner SJ, Kollman PA, Case DA et al. A new force field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 1984; 106:765–784.
  • Katz BA, Kossiakoff A. The crystallographically determined structures of atypical strained disulfides engineered into subtilisin. J Biol Chem 1986; 261: 15480–15485.
  • Pjura PE, Matsumura M, Wozniak JA, Matthews BW. Structure of a thermostable disulfide-bridge mutant of phage T4 lysozyme shows that an engineered cross-link in a flexible region does not increase the rigidity of the folded protein. Biochemistry 1990; 29: 2592–2598.
  • Wells JA, Power DB. In vivo formation and stability of engineered disulfide bonds in subtilisin. J Biol Chem 1986; 261: 6564–6570.
  • Chang Y, Mochalkin I, McCance SG, Cheng B, Tulinsky A, Castellino FJ. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen. Biochemistry 1998; 37: 3258–3271.
  • Mulligan-Kehoe MJ, Wagner R, Wieland C, Powell R. A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product. J Biol Chem 2001; 276: 8588–8596.
  • Brandt W, Golbraikh A, Tager M, Lendeckel U. A molecular mechanism for the cleavage of a disulfide bond as the primary function of agonist binding to G-protein-coupled receptors based on theoretical calculations supported by experiments. Eur J Biochem 1999; 261: 89–97.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.